BROWSE ALL ARTICLES BY TOPIC

Articles by Section - Regular Article

Listing articles 1 to 10 of 481

News: Synthetic Hydrogel (aka Squishy Gel) Could Revolutionize Arthritis Treatment

Squishy gel could include a chemical compound capable of helping repair, restore or regenerate cartilage in a joint.

Meeting: MicroRNA-Based Therapeutics Hold Promise Against Lupus, Other Rheumatic Diseases Note Experts at the ACR/ARHP’s 2013 Annual Meeting

Studies suggest deregulation, dysfunction of miRNAs in human, mice models of lupus may be future targets for gene therapy

Meeting: Tips for Treating Pain, Depression in Patients with Rheumatic Disease Offered at the ACR/ARHP’s 2013 Annual Meeting

Observational pain scales, diagnostic tools, pharmacologic interventions, and support from psychologists, caregivers recommended

Meeting: Global Perspectives on Managing Rheumatoid Arthritis Addressed at the 2013 ACR/ARHP Annual Meeting

Poverty, poor access to healthcare, cultural myths present challenges for rheumatologists caring for patients with RA in developing economic regions

Meeting: Therapeutic Value of Colchicine in Osteoarthritis, Cardiovascular Disease Explored at the ACR/ARHP Winter Rheumatology Symposium

Drug's antiinflammatory properties may help alleviate pain in patients with OA, reduce risk of myocardial infarction, but toxicity, drug interactions need to be considered

Meeting: Treatment Options, Guidelines for Managing Gout Discussed at the ACR/ARHP Winter Rheumatology Symposium

Better understanding of goals, effect of gout therapy with nonsteroidal anti-inflammatory drugs, urate lowering medication needed to improve quality of care

Meeting: Treating Early-Stage Spondyloarthritis May Prevent Disease Progression, Say Researchers at the ACR/ARHP Winter Rheumatology Symposium

Therapy with tumor necrosis factor inhibitors, nonsteroidal antiinflammatory drugs, ustekinumab in early stages of osteitis may halt molecular switching to bone-forming phenotype characteristic of SpA

Meeting: Methotrexate May Mitigate Inflammatory Bone Disease Note Experts at the ACR/ARHP Winter Rheumatology Symposium

By regulating molecules key to osteoclast/osteoblast processes, methotrexate may reduce bone destruction in inflammatory arthritis, osteolysis, especially in combination with adenosine

Features: How Rheumatologists Can Boost Patient Understanding of Educational Materials

Choosing appropriate, pre-written disease fact sheets, or writing your own educational documents can help patients with low health literacy comprehend information about their condition

Features: Exploring Kawasaki Disease

New epidemiologic data, clinical studies have shed light on diagnosis, treatments, patient outcomes for this childhood disease, but etiology is still unknown

Pagination

Advertisement

Current Issue

Current Issue

April 2014

Site Search

Site Navigation

Advertisements


 

Advertisements